233 related articles for article (PubMed ID: 30046393)
1. Clonal heterogeneity of
Schranz K; Hubmann M; Harin E; Vosberg S; Herold T; Metzeler KH; Rothenberg-Thurley M; Janke H; Bräundl K; Ksienzyk B; Batcha AMN; Schaaf S; Schneider S; Bohlander SK; Görlich D; Berdel WE; Wörmann BJ; Braess J; Krebs S; Hiddemann W; Mansmann U; Spiekermann K; Greif PA
Oncotarget; 2018 Jul; 9(53):30128-30145. PubMed ID: 30046393
[TBL] [Abstract][Full Text] [Related]
2. Detection the Frequency and Characteristics of FLT3 Internal Tandem Duplication Mutations by Capillary Electrophoresis Assay and Next-Generation Sequencing in.
Ma L; Cao Y; Jiang Y; Cong X; Lu S; Shen J; Liu Q; Han C; Zhan Y; Cao Y
Clin Lab; 2016 Oct; 62(10):2065-2072. PubMed ID: 28164543
[TBL] [Abstract][Full Text] [Related]
3. Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples.
Cloos J; Goemans BF; Hess CJ; van Oostveen JW; Waisfisz Q; Corthals S; de Lange D; Boeckx N; Hählen K; Reinhardt D; Creutzig U; Schuurhuis GJ; Zwaan ChM; Kaspers GJ
Leukemia; 2006 Jul; 20(7):1217-20. PubMed ID: 16642044
[TBL] [Abstract][Full Text] [Related]
4. A DNA pool of FLT3-ITD positive DNA samples can be used efficiently for analytical evaluation of NGS-based FLT3-ITD quantitation - Testing several different ITD sequences and rates, simultaneously.
Mezei ZA; Tornai D; Földesi R; Madar L; Sümegi A; Papp M; Antal-Szalmás P
J Biotechnol; 2019 Sep; 303():25-29. PubMed ID: 31302157
[TBL] [Abstract][Full Text] [Related]
5. Accurate Detection and Quantification of FLT3 Internal Tandem Duplications in Clinical Hybrid Capture Next-Generation Sequencing Data.
Tung JK; Suarez CJ; Chiang T; Zehnder JL; Stehr H
J Mol Diagn; 2021 Oct; 23(10):1404-1413. PubMed ID: 34363960
[TBL] [Abstract][Full Text] [Related]
6. Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data.
Spencer DH; Abel HJ; Lockwood CM; Payton JE; Szankasi P; Kelley TW; Kulkarni S; Pfeifer JD; Duncavage EJ
J Mol Diagn; 2013 Jan; 15(1):81-93. PubMed ID: 23159595
[TBL] [Abstract][Full Text] [Related]
7. [Application of High-throughput Sequencing in Acute Myeloid Leukemia Patients with Positive FLT3-ITD].
Ma L; Jiang YW; Wang ST; Liu Q; Cong X; Shen J; Cao YY; Cao YT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):381-7. PubMed ID: 27150996
[TBL] [Abstract][Full Text] [Related]
8. Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients.
Zuffa E; Franchini E; Papayannidis C; Baldazzi C; Simonetti G; Testoni N; Abbenante MC; Paolini S; Sartor C; Parisi S; Marconi G; Cattina F; Bochicchio MT; Venturi C; Ottaviani E; Cavo M; Martinelli G
Oncotarget; 2015 Oct; 6(31):31284-94. PubMed ID: 26384303
[TBL] [Abstract][Full Text] [Related]
9. Outcome of FLT3-ITD-positive acute myeloid leukemia: impact of allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment.
Fleischmann M; Schnetzke U; Schrenk KG; Schmidt V; Sayer HG; Hilgendorf I; Hochhaus A; Scholl S
J Cancer Res Clin Oncol; 2017 Feb; 143(2):337-345. PubMed ID: 27778197
[TBL] [Abstract][Full Text] [Related]
10. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
[TBL] [Abstract][Full Text] [Related]
11. Patient-specific analysis of FLT3 internal tandem duplications for the prognostication and monitoring of acute myeloid leukemia.
Schiller J; Praulich I; Krings Rocha C; Kreuzer KA
Eur J Haematol; 2012 Jul; 89(1):53-62. PubMed ID: 22458420
[TBL] [Abstract][Full Text] [Related]
12.
Lee JM; Park S; Hwang I; Kang D; Cho BS; Kim HJ; Ahn A; Kim M; Kim Y
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551616
[TBL] [Abstract][Full Text] [Related]
13. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK
Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.
Shamaa S; Laimon N; Aladle DA; Azmy E; Elghannam DM; Salem DA; Taalab MM
Hematology; 2014 Jan; 19(1):22-30. PubMed ID: 23540998
[TBL] [Abstract][Full Text] [Related]
15. Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation.
Marhäll A; Heidel F; Fischer T; Rönnstrand L
Ann Hematol; 2018 May; 97(5):773-780. PubMed ID: 29372308
[TBL] [Abstract][Full Text] [Related]
16. Evolution of FLT3-ITD and D835 activating point mutations in relapsing acute myeloid leukemia and response to salvage therapy.
Tiesmeier J; Müller-Tidow C; Westermann A; Czwalinna A; Hoffmann M; Krauter J; Heil G; Ganser A; Serve H; Verbeek W
Leuk Res; 2004 Oct; 28(10):1069-74. PubMed ID: 15289019
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of FLT3 gene expression level and internal tandem duplication mutation in acute myeloid leukemia and its clinical significance].
Wang YG; Liu XH; Liang Y; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):741-5. PubMed ID: 19176010
[TBL] [Abstract][Full Text] [Related]
18. Quantitative fragment analysis of FLT3-ITD efficiently identifying poor prognostic group with high mutant allele burden or long ITD length.
Kim Y; Lee GD; Park J; Yoon JH; Kim HJ; Min WS; Kim M
Blood Cancer J; 2015 Aug; 5(8):e336. PubMed ID: 26832846
[TBL] [Abstract][Full Text] [Related]
19. A Novel Tandem Duplication Assay to Detect Minimal Residual Disease in FLT3/ITD AML.
Lin MT; Tseng LH; Dudley JC; Riel S; Tsai H; Zheng G; Pratz KW; Levis MJ; Gocke CD
Mol Diagn Ther; 2015 Dec; 19(6):409-17. PubMed ID: 26446915
[TBL] [Abstract][Full Text] [Related]
20. Subclinical minute FLT3-ITD clone can be detected in clinically FLT3-ITD-negative acute myeloid leukaemia at diagnosis.
Yokoyama S; Onozawa M; Yoshida S; Miyashita N; Kimura H; Takahashi S; Matsukawa T; Goto H; Fujisawa S; Miki K; Hidaka D; Hashiguchi J; Wakasa K; Ibata M; Takeda Y; Shigematsu A; Fujimoto K; Tsutsumi Y; Mori A; Ishihara T; Kakinoki Y; Kondo T; Hashimoto D; Teshima T
Br J Haematol; 2023 Jun; 201(6):1144-1152. PubMed ID: 37067758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
